Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04520503
Other study ID # pre-induction EEG
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 9, 2020
Est. completion date February 28, 2022

Study information

Verified date October 2023
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The induction dose of propofol is generally determined based on patients' characteristics, underlying disease, general condition, and also by clinician's experiences. However, It is difficult to anticipate and objectively calculate an adequate dose of propofol for every patient considering the variability of an individual's response to propofol. If there is a specific pattern in EEG prior to induction of anesthesia that can provide information about the patient's susceptibility to propofol, every induction may be performed far more smoothly with a precisely optimized dose of propofol for each patient. The study is to find a relationship between the pre-induction EEG pattern of adult patients and their sensitivity to propofol.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date February 28, 2022
Est. primary completion date February 28, 2022
Accepts healthy volunteers No
Gender All
Age group 20 Years to 89 Years
Eligibility Inclusion Criteria: - Adult patients undergoing general anesthesia Exclusion Criteria: - Patients undergoing cardiac or brain surgery - Patients with neurological deficit or impaired communication (Glasgow Coma Scale < 15) - Unstable vital sign (cardiogenic, hemorrhagic, septic shock) - Patients with eclampsia - Patients who administered preoperative anxiolytics - Patients who do not require intubation - Patients who are considered unsuitable for the study

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Propofol
The dose of propofol required for loss of consciousness and the total induction dose of propofol will be recorded for every patients.
Device:
EEG monitoring
The processed EEG spectrogram and indices, such as patient status index, 95% spectral edge frequency, and suppression ratio, will be obtained from Sedline monitoring device. The raw pre-induction EEG will be extracted from Sedline at the end of induction and it will be analyzed by an external software to calculate the mean frequency, frequency band power and its distribution.

Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Absolute and Relative power in distinct frequency (% d: 1-4 Hz, % ?: 5-8 Hz, % a: 9-12 Hz, % ß: 13-25 Hz) Relative power in distinct frequency (% d: 1-4 Hz, % ?: 5-8 Hz, % a: 9-12 Hz, % ß: 13-25 Hz) During the induction of anesthesia (up to 15 min)
Primary Processed EEG index (PSI; patient state index) Processed EEG index (PSI; patient state index) During the induction of anesthesia (up to 15 min)
Primary Mean frequency and 95% spectral edge frequency (Hz) Mean frequency and 95% spectral edge frequency (Hz) During the induction of anesthesia (up to 15 min)
Primary Burst suppression ratio (%) Burst suppression ratio (%) During the induction of anesthesia (up to 15 min)
Secondary The effect-site concentrations of propofol at loss of consciousness (µg/ml) The effect-site concentrations of propofol at loss of consciousness (µg/ml) During the induction of anesthesia (up to 15 min)
Secondary The dose of propofol required for loss of consciousness (mg) The dose of propofol required for loss of consciousness (mg) During the induction of anesthesia (up to 15 min)
Secondary Total amount of propofol used (mg) Total amount of propofol used (mg) During the induction of anesthesia (up to 15 min)
Secondary Time to loss of consciousness (second) Time to loss of consciousness (second) after the start of induction During the induction of anesthesia (up to 15 min)
Secondary Vital sign - blood pressure Check blood pressure (mmHg) During the induction of anesthesia (up to 15 min)
Secondary Vital sign - heart rate Check heart rate (beats per minute) During the induction of anesthesia (up to 15 min)
Secondary Administration of vasopressors (ephedrine, phenylephrine, epinephrine, etc) Administration of vasopressors (ephedrine (mg), phenylephrine (mcg), epinephrine (mcg), etc) During the induction of anesthesia (up to 15 min)
See also
  Status Clinical Trial Phase
Completed NCT05158426 - Application of the Propofol Precise Infusion Model
Completed NCT02199522 - Clinical Observation of Titration Induction and Convention Induction of Propofol N/A
Completed NCT01435785 - Performance Evaluation of Four Pharmacokinetic-Pharmacodynamic(PKPD) Models of Propofol in Elderly Patients N/A